Future directions for cardiovascular disease comparative effectiveness research

Report of a workshop sponsored by the national heart, lung, and blood institute

Mark A. Hlatky, Pamela S. Douglas, Nakela L. Cook, Barbara Wells, Emelia J. Benjamin, Kay Dickersin, David C. Goff, Alan T. Hirsch, Elaine M. Hylek, Eric D. Peterson, Véronique L. Roger, Joseph V. Selby, James E. Udelson, Michael S. Lauer

Research output: Contribution to journalArticle

Abstract

Comparative effectiveness research (CER) aims to provide decision makers with the evidence needed to evaluate the benefits and harms of alternative clinical management strategies. CER has become a national priority, with considerable new research funding allocated. Cardiovascular disease is a priority area for CER. This workshop report provides an overview of CER methods, with an emphasis on practical clinical trials and observational treatment comparisons. The report also details recommendations to the National Heart, Lung, and Blood Institute for a new framework for evidence development to foster cardiovascular CER, and specific studies to address 8 clinical issues identified by the Institute of Medicine as high priorities for cardiovascular CER.

Original languageEnglish (US)
Pages (from-to)569-580
Number of pages12
JournalJournal of the American College of Cardiology
Volume60
Issue number7
DOIs
StatePublished - Aug 14 2012

Fingerprint

Comparative Effectiveness Research
National Heart, Lung, and Blood Institute (U.S.)
Cardiovascular Diseases
Education
Pragmatic Clinical Trials
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Direction compound
Research

Keywords

  • clinical trials
  • comparative effectiveness
  • research methods

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Future directions for cardiovascular disease comparative effectiveness research : Report of a workshop sponsored by the national heart, lung, and blood institute. / Hlatky, Mark A.; Douglas, Pamela S.; Cook, Nakela L.; Wells, Barbara; Benjamin, Emelia J.; Dickersin, Kay; Goff, David C.; Hirsch, Alan T.; Hylek, Elaine M.; Peterson, Eric D.; Roger, Véronique L.; Selby, Joseph V.; Udelson, James E.; Lauer, Michael S.

In: Journal of the American College of Cardiology, Vol. 60, No. 7, 14.08.2012, p. 569-580.

Research output: Contribution to journalArticle

Hlatky, MA, Douglas, PS, Cook, NL, Wells, B, Benjamin, EJ, Dickersin, K, Goff, DC, Hirsch, AT, Hylek, EM, Peterson, ED, Roger, VL, Selby, JV, Udelson, JE & Lauer, MS 2012, 'Future directions for cardiovascular disease comparative effectiveness research: Report of a workshop sponsored by the national heart, lung, and blood institute', Journal of the American College of Cardiology, vol. 60, no. 7, pp. 569-580. https://doi.org/10.1016/j.jacc.2011.12.057
Hlatky, Mark A. ; Douglas, Pamela S. ; Cook, Nakela L. ; Wells, Barbara ; Benjamin, Emelia J. ; Dickersin, Kay ; Goff, David C. ; Hirsch, Alan T. ; Hylek, Elaine M. ; Peterson, Eric D. ; Roger, Véronique L. ; Selby, Joseph V. ; Udelson, James E. ; Lauer, Michael S. / Future directions for cardiovascular disease comparative effectiveness research : Report of a workshop sponsored by the national heart, lung, and blood institute. In: Journal of the American College of Cardiology. 2012 ; Vol. 60, No. 7. pp. 569-580.
@article{a53802e398f64950a03aa8422524c8f3,
title = "Future directions for cardiovascular disease comparative effectiveness research: Report of a workshop sponsored by the national heart, lung, and blood institute",
abstract = "Comparative effectiveness research (CER) aims to provide decision makers with the evidence needed to evaluate the benefits and harms of alternative clinical management strategies. CER has become a national priority, with considerable new research funding allocated. Cardiovascular disease is a priority area for CER. This workshop report provides an overview of CER methods, with an emphasis on practical clinical trials and observational treatment comparisons. The report also details recommendations to the National Heart, Lung, and Blood Institute for a new framework for evidence development to foster cardiovascular CER, and specific studies to address 8 clinical issues identified by the Institute of Medicine as high priorities for cardiovascular CER.",
keywords = "clinical trials, comparative effectiveness, research methods",
author = "Hlatky, {Mark A.} and Douglas, {Pamela S.} and Cook, {Nakela L.} and Barbara Wells and Benjamin, {Emelia J.} and Kay Dickersin and Goff, {David C.} and Hirsch, {Alan T.} and Hylek, {Elaine M.} and Peterson, {Eric D.} and Roger, {V{\'e}ronique L.} and Selby, {Joseph V.} and Udelson, {James E.} and Lauer, {Michael S.}",
year = "2012",
month = "8",
day = "14",
doi = "10.1016/j.jacc.2011.12.057",
language = "English (US)",
volume = "60",
pages = "569--580",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Future directions for cardiovascular disease comparative effectiveness research

T2 - Report of a workshop sponsored by the national heart, lung, and blood institute

AU - Hlatky, Mark A.

AU - Douglas, Pamela S.

AU - Cook, Nakela L.

AU - Wells, Barbara

AU - Benjamin, Emelia J.

AU - Dickersin, Kay

AU - Goff, David C.

AU - Hirsch, Alan T.

AU - Hylek, Elaine M.

AU - Peterson, Eric D.

AU - Roger, Véronique L.

AU - Selby, Joseph V.

AU - Udelson, James E.

AU - Lauer, Michael S.

PY - 2012/8/14

Y1 - 2012/8/14

N2 - Comparative effectiveness research (CER) aims to provide decision makers with the evidence needed to evaluate the benefits and harms of alternative clinical management strategies. CER has become a national priority, with considerable new research funding allocated. Cardiovascular disease is a priority area for CER. This workshop report provides an overview of CER methods, with an emphasis on practical clinical trials and observational treatment comparisons. The report also details recommendations to the National Heart, Lung, and Blood Institute for a new framework for evidence development to foster cardiovascular CER, and specific studies to address 8 clinical issues identified by the Institute of Medicine as high priorities for cardiovascular CER.

AB - Comparative effectiveness research (CER) aims to provide decision makers with the evidence needed to evaluate the benefits and harms of alternative clinical management strategies. CER has become a national priority, with considerable new research funding allocated. Cardiovascular disease is a priority area for CER. This workshop report provides an overview of CER methods, with an emphasis on practical clinical trials and observational treatment comparisons. The report also details recommendations to the National Heart, Lung, and Blood Institute for a new framework for evidence development to foster cardiovascular CER, and specific studies to address 8 clinical issues identified by the Institute of Medicine as high priorities for cardiovascular CER.

KW - clinical trials

KW - comparative effectiveness

KW - research methods

UR - http://www.scopus.com/inward/record.url?scp=84864720888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864720888&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2011.12.057

DO - 10.1016/j.jacc.2011.12.057

M3 - Article

VL - 60

SP - 569

EP - 580

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 7

ER -